|
January Health Tip by Dr. Hahn-Cover
Vaccines in the News
2006 was an exciting year in health care, with two new vaccines licensed for use. One of these vaccines may be important for you to consider; we offer both at Fairview Internal Medicine. If you feel you would benefit from one of these vaccines, please call your insurance to learn what your cost will be. If you have any questions about these or other vaccines, please discuss with your doctor at your next appointment.
Gardasil (HPV) vaccine
This vaccine protects against the Human Papilloma Virus (HPV). This virus can cause genital warts and can lead to cervical cancer. HPV is transmitted by sexual contact. The new vaccine is recommended for girls around the age of 11-12, but is also important for young women to consider.
- Approved for use in women between ages 11 and 26.
- A series of 3 injections.
- Protects against 4 of the most common strains of HPV. These 4 strains cause up to 70% of cases of cervical cancer, and up to 90% of cases of genital warts in women.
Zostavax (shingles) vaccine
This vaccine protects against the Herpes zoster virus, which causes a first infection with chicken pox and can cause recurrent outbreaks called shingles. The vaccine is designed to protect against shingles outbreaks.
- Approved for use in adults ages 60 and older. Most effective in the 60-80 year old group.
- Not approved for use in people who have not had chicken pox, or who have already had shingles. People who have not had chicken pox should have the vaccine developed specifically for chicken pox protection. People who have already had shingles are protected from a recurrence by the prior outbreak/shingles infection.
For more information about these or other vaccines, please visit:
Kristin Hahn-Cover, MD
Assistant Professor of Clinical Medicine
Department of Internal Medicine
For more information:
MU Health Sciences Library
|